Erratum to: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors

被引：0
|
作者：
Karin Oechsle
Carsten Bokemeyer
Friedemann Honecker
机构：
[1] University Medical Center Eppendorf,Departments of Oncology, Hematology, Bone Marrow Transplantation and Pneumology
来源：
Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷 / 1期
关键词：
D O I：
10.1007/s00432-009-0697-y
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors
    Karin Oechsle
    Carsten Bokemeyer
    Friedemann Honecker
    Journal of Cancer Research and Clinical Oncology, 2010, 136
  • [2] Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors
    Oechsle, Karin
    Bokemeyer, Carsten
    Honecker, Friedemann
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (01) : 165 - 167
  • [3] Treatment of patients with cisplatin-refractory germ cell tumors
    Koychev, D.
    Honecker, F.
    Bokemeyer, C.
    Albers, P.
    ONKOLOGE, 2013, 19 (07): : 564 - 567
  • [4] Sunitinib in Patients with Cisplatin-Refractory Germ Cell Tumors
    Reckova, Maria
    Mego, Michel
    Sycova-Mila, Zuzana
    Obertova, Jana
    Svetlovska, Dana
    Mardiak, Jozef
    ONKOLOGIE, 2012, 35 (7-8): : 455 - 456
  • [5] Salvage Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin (TIP) in Relapsed or Cisplatin-Refractory Germ Cell Tumors
    Park, Silvia
    Lee, Soohyeon
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Kang, Won Ki
    Park, Young Suk
    Lim, Ho Yeong
    ONKOLOGIE, 2011, 34 (8-9): : 416 - 420
  • [6] Long term outcome in patients with cisplatin-refractory or multiply relapsed germ cell tumors following treatment with gemcibine and oxaliplatin ± paclitaxel.
    Oechsle, K.
    Kollmannsberger, C. K.
    Honecker, F.
    Mayer, F.
    Waller, C. F.
    Boehlke, I.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Combination chemotherapy with gemcitabine, oxaliplatin and paclitaxel in patients with cisplatin-refractory or relapsed germ cell tumors (gct)
    Oechsle, K.
    Bokemeyer, C.
    Honecker, F.
    Mayer, F.
    Waller, C. F.
    Boehlke, I.
    Hartmann, J. T.
    Kollmannsberger, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update
    Koychev, D.
    Oechsle, K.
    Bokemeyer, C.
    Honecker, F.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2011, 34 (04): : E266 - E273
  • [9] Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer
    Kollmannsberger, C
    Gerl, A
    Schleucher, N
    Beyer, J
    Kuczyk, M
    Rick, O
    Gasper, J
    Sosada, M
    Rie, C
    Kanz, L
    Bokemeyer, C
    ANTI-CANCER DRUGS, 2000, 11 (07) : 535 - 539
  • [10] Sunitinib in patients with multiply relapsed or cisplatin-refractory germ cell cancer: A CLOG/GTCSG cooperative phase II study.
    Kollmannsberger, C. K.
    Oechsle, K.
    Cheng, T.
    Mayer, F.
    Czaykowski, P.
    Winquist, E.
    Wood, L.
    Fenner, M.
    Chi, K. N.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345